Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 27 | BSPED2011 | Next issue

39th Meeting of the British Society for Paediatric Endocrinology and Diabetes

Speaker Abstracts

Symposium 3–Insulin Resistance and Type 2 Diabetes: Novel Insights

ea0027s21 | Symposium 3–Insulin Resistance and Type 2 Diabetes: Novel Insights | BSPED2011

Genetic disorders of insulin signalling

Semple Robert K

Driven by the rising global tide of obesity, insulin resistance is already at pandemic levels, and is intimately associated with major pathologies including type 2 diabetes, ovulatory dysfunction and hyperandrogenism, the spectrum of fatty liver disease, and disorders of growth including cancer. Yet despite intensive study of prevalent forms of the condition, major questions remain both about the nature of the genetic predisposition to insulin resistance, and the mechanisms li...

ea0027s22 | Symposium 3–Insulin Resistance and Type 2 Diabetes: Novel Insights | BSPED2011

Early intervention in type 2 diabetes mellitus

Holman Rury

The number of people worldwide with diabetes is predicted to exceed 370 million by the year 2030. Over 90% of these will have type 2 diabetes with a twofold greater risk of heart disease and stroke than in the general population, and a reduction in life expectancy of five or more years.Type 2 diabetes is a condition of relative insulin deficiency. Insulin secretory responses to meal challenges are delayed and prolonged and, although fasting insulin level...